ImpediMed Completes Asset Sale of XiTRON Technologies, Inc.
Filed with ASX · · 1 page · English
Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings CallEarlier from ImpediMed
- S&P DJI Announces September 2018 Quarterly Rebalance
- Response to ASX Aware Query
- L-Dex Suggested as a New Standard of Care
- PREVENT Trial Results Published - Outstanding Initial Data
- Appendix 4C - Quarter ended 30 June 2018
Later from ImpediMed
- Appendix 4C - Quarter ended 30 September 2018
- Ascension National Purchasing Agreement Received
- PREVENT Trial accepted for Publication and Presentation
- Appendix 4C - Quarter ended 31 December 2018
- S&P DJI Announces March 2019 Quarterly Rebalance
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed